Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associate Professor at the University of Toronto.  She has been involved with the development of the Diabetes Canada clinical practice guidelines since 2003 and is serving as Chair of the Scientific Planning Committee for the 2023 and 2024 American Diabetes Association annual scientific meetings, an Associate Editor for Diabetes Care and co-host of the podcast series “Diabetes Care On Air”.    She is also the creator of The Med Ed Pledge – an initiative to increase Diversity & Inclusion in continuing medical education.

Dr. Cheng declares sources of funding and relationships with the following commercial stakeholders in the healthcare sector:

Abbott, Amgen, Astra Zeneca, Bausch, Bayer, Boehringer Ingelheim, Dexcom, Eisai, Eli Lilly, GSK, HLS Therapeutics, Insulet, Janssen, Medtronic, Merck, Novo Nordisk, Pfizer, Sanofi, Takeda.